Forget Crispr Therapeutics: This Gene-Editing Pick Attracts
The gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
Side-by-side look at the strengths and weaknesses of zero-based budgeting and envelope systems to help you decide which suits your goals.
28,655 articlesThe gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
A Madrid court clears Shakira of a 2011 tax-year fraud claim and orders a 60 million euro refund, including interest....
JPMorgan Chase named Doug Petno and Troy Rohrbaugh as co-presidents, effective immediately, as the board advances its...
As Baidu surges, a hedge fund’s multi-million bet raises questions about AI, China’s digital economy, and portfolio c...
Big-name bets via 13F filings often reveal more about risk management than marketing hype. This quarter, billionaire ...
July can surprise markets, and Netflix is no exception. This guide breaks down three practical reasons netflix stock ...
A fresh analysis pegs the average 65-year-old's long-term care fund at $135,000 for high-intensity needs, with notabl...
Nike faces a pivotal earnings moment as June 30 approaches. This guide breaks down whether you should nike stock befo...
When a top investor adds to a position after a selloff, it can reveal confidence not just in a single company, but in...
Oil hovering near $100 a barrel is signaling more than higher gas bills. The price surge threatens costs for plastics...
A high-net-worth retiree with a $2.1 million 401(K) moves to Nevada to minimize state taxes before his first RMD at 7...
In 2026, property owners are selling experiences, not just space. Lenders are adjusting terms as tenants sign leases ...